retatrutide side effects phase 2 trial Clinical – My Endo Consult Retatrutide Phase 2: Type 2

A Mayo Clinic retrospective (Hurtado et al., 2024) found postmenopausal women on semaglutide achieved greater weight loss when concurrently on hormone therapy

Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis

Kathy Zhou: Yeah, so I would say honestly, anyone with Type 2 I should have qualified that Type 2 to diabetes, which is where it's approved, would certainly probably benefit from this medication, even more so if you have something like, for example, fatty liver or cardiovascular risk or disease that's already there or kidney disease even with these medications potentially could be particularly helpful

The two faces of reactive oxygen species in cancer